Literature DB >> 36138166

Inflammation-associated nitrate facilitates ectopic colonization of oral bacterium Veillonella parvula in the intestine.

Daniel F Rojas-Tapias1,2,3, Eric M Brown1,2, Emily R Temple1, Michelle A Onyekaba1, Ahmed M T Mohamed1,2, Kellyanne Duncan1,2, Melanie Schirmer1,4, Rebecca L Walker1, Toufic Mayassi1,2, Kerry A Pierce5, Julián Ávila-Pacheco5, Clary B Clish5, Hera Vlamakis1,6, Ramnik J Xavier7,8,9.   

Abstract

Colonization of the intestine by oral microbes has been linked to multiple diseases such as inflammatory bowel disease and colon cancer, yet mechanisms allowing expansion in this niche remain largely unknown. Veillonella parvula, an asaccharolytic, anaerobic, oral microbe that derives energy from organic acids, increases in abundance in the intestine of patients with inflammatory bowel disease. Here we show that nitrate, a signature metabolite of inflammation, allows V. parvula to transition from fermentation to anaerobic respiration. Nitrate respiration, through the narGHJI operon, boosted Veillonella growth on organic acids and also modulated its metabolic repertoire, allowing it to use amino acids and peptides as carbon sources. This metabolic shift was accompanied by changes in carbon metabolism and ATP production pathways. Nitrate respiration was fundamental for ectopic colonization in a mouse model of colitis, because a V. parvula narG deletion mutant colonized significantly less than a wild-type strain during inflammation. These results suggest that V. parvula harness conditions present during inflammation to colonize in the intestine.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36138166     DOI: 10.1038/s41564-022-01224-7

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   30.964


  61 in total

1.  Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases.

Authors:  Ashwin N Ananthakrishnan; Chengwei Luo; Vijay Yajnik; Hamed Khalili; John J Garber; Betsy W Stevens; Thomas Cleland; Ramnik J Xavier
Journal:  Cell Host Microbe       Date:  2017-05-10       Impact factor: 21.023

2.  Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients.

Authors:  Maria Laura Santoru; Cristina Piras; Antonio Murgia; Vanessa Palmas; Tania Camboni; Sonia Liggi; Ivan Ibba; Maria Antonia Lai; Sandro Orrù; Sylvain Blois; Anna Lisa Loizedda; Julian Leether Griffin; Paolo Usai; Pierluigi Caboni; Luigi Atzori; Aldo Manzin
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

3.  Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.

Authors:  Aleksandar D Kostic; Eunyoung Chun; Lauren Robertson; Jonathan N Glickman; Carey Ann Gallini; Monia Michaud; Thomas E Clancy; Daniel C Chung; Paul Lochhead; Georgina L Hold; Emad M El-Omar; Dean Brenner; Charles S Fuchs; Matthew Meyerson; Wendy S Garrett
Journal:  Cell Host Microbe       Date:  2013-08-14       Impact factor: 21.023

4.  The human oral microbiome.

Authors:  Floyd E Dewhirst; Tuste Chen; Jacques Izard; Bruce J Paster; Anne C R Tanner; Wen-Han Yu; Abirami Lakshmanan; William G Wade
Journal:  J Bacteriol       Date:  2010-07-23       Impact factor: 3.490

5.  The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis.

Authors:  Sho Kitamoto; Hiroko Nagao-Kitamoto; Yizu Jiao; Merritt G Gillilland; Atsushi Hayashi; Jin Imai; Kohei Sugihara; Mao Miyoshi; Jennifer C Brazil; Peter Kuffa; Brett D Hill; Syed M Rizvi; Fei Wen; Shrinivas Bishu; Naohiro Inohara; Kathryn A Eaton; Asma Nusrat; Yu L Lei; William V Giannobile; Nobuhiko Kamada
Journal:  Cell       Date:  2020-06-16       Impact factor: 41.582

6.  Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation.

Authors:  Koji Atarashi; Wataru Suda; Chengwei Luo; Takaaki Kawaguchi; Iori Motoo; Seiko Narushima; Yuya Kiguchi; Keiko Yasuma; Eiichiro Watanabe; Takeshi Tanoue; Christoph A Thaiss; Mayuko Sato; Kiminori Toyooka; Heba S Said; Hirokazu Yamagami; Scott A Rice; Dirk Gevers; Ryan C Johnson; Julia A Segre; Kong Chen; Jay K Kolls; Eran Elinav; Hidetoshi Morita; Ramnik J Xavier; Masahira Hattori; Kenya Honda
Journal:  Science       Date:  2017-10-20       Impact factor: 47.728

7.  The treatment-naive microbiome in new-onset Crohn's disease.

Authors:  Subra Kugathasan; Lee A Denson; Dirk Gevers; Yoshiki Vázquez-Baeza; Will Van Treuren; Boyu Ren; Emma Schwager; Dan Knights; Se Jin Song; Moran Yassour; Xochitl C Morgan; Aleksandar D Kostic; Chengwei Luo; Antonio González; Daniel McDonald; Yael Haberman; Thomas Walters; Susan Baker; Joel Rosh; Michael Stephens; Melvin Heyman; James Markowitz; Robert Baldassano; Anne Griffiths; Francisco Sylvester; David Mack; Sandra Kim; Wallace Crandall; Jeffrey Hyams; Curtis Huttenhower; Rob Knight; Ramnik J Xavier
Journal:  Cell Host Microbe       Date:  2014-03-12       Impact factor: 21.023

Review 8.  The oral microbiota: dynamic communities and host interactions.

Authors:  Richard J Lamont; Hyun Koo; George Hajishengallis
Journal:  Nat Rev Microbiol       Date:  2018-12       Impact factor: 60.633

9.  Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.

Authors:  Kelly A Shaw; Madeline Bertha; Tatyana Hofmekler; Pankaj Chopra; Tommi Vatanen; Abhiram Srivatsa; Jarod Prince; Archana Kumar; Cary Sauer; Michael E Zwick; Glen A Satten; Aleksandar D Kostic; Jennifer G Mulle; Ramnik J Xavier; Subra Kugathasan
Journal:  Genome Med       Date:  2016-07-13       Impact factor: 11.117

10.  The oral microbiota in colorectal cancer is distinctive and predictive.

Authors:  Burkhardt Flemer; Ryan D Warren; Maurice P Barrett; Katryna Cisek; Anubhav Das; Ian B Jeffery; Eimear Hurley; Micheal O'Riordain; Fergus Shanahan; Paul W O'Toole
Journal:  Gut       Date:  2017-10-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.